0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurodiagnostics Market by Technology (Invasive, Noninvasive), Application (Alzheimer's Disease, Brain Tumor, Epilepsy), End User - Global Forecast 2025-2030- Product Image
Neurodiagnostics Market by Technology (Invasive, Noninvasive), Application (Alzheimer's Disease, Brain Tumor, Epilepsy), End User - Global Forecast 2025-2030- Product Image
Sale

Neurodiagnostics Market by Technology (Invasive, Noninvasive), Application (Alzheimer's Disease, Brain Tumor, Epilepsy), End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5014094
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Neurodiagnostics Market is rapidly evolving as advanced diagnostic tools become integral in neurology and clinical practice. Growth is propelled by increased neurological disease prevalence and robust investment in early-detection technologies. This report delivers actionable insights designed specifically for senior healthcare and medical technology leaders seeking a holistic understanding of current and emerging trends driving strategic decision-making.

Market Snapshot: Neurodiagnostics Market Trends and Growth

The Neurodiagnostics Market grew from USD 7.97 billion in 2024 to USD 8.70 billion in 2025. It is expected to continue growing at a CAGR of 8.75%, reaching USD 13.19 billion by 2030. The sector’s expansion is anchored by rising neurological disorder incidence, adoption of high-precision diagnostic imaging, and increased healthcare infrastructure investment globally. Market competitiveness is intensifying across established and emerging regions as technological innovation and strategic partnerships shape opportunities.

Scope & Segmentation of the Neurodiagnostics Market

This comprehensive market analysis explores the full spectrum of neurodiagnostics technologies, applications, and end users across all key geographies. Segmentation enables decision-makers to identify high-growth areas and align solutions with evolving healthcare demands.

  • Technology: Invasive solutions such as depth electrode monitoring and electrocorticography; noninvasive tools including electrophysiology and advanced imaging modalities.
  • Application Areas: Alzheimer’s disease (including Lewy body and vascular dementia), brain tumor assessment, epilepsy (focal and generalized), multiple sclerosis, stroke diagnostics (hemorrhagic and ischemic), and traumatic brain injury.
  • End Users: Ambulatory clinics (including neurology and outpatient rehabilitation centers), diagnostic centers (hospital-owned and independent), hospitals (general and specialty), home care, and research institutes.
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, and Argentina), Europe, Middle East & Africa (covering major economies and key healthcare markets), and Asia-Pacific (notably China, India, Japan, Australia, and additional emerging regions).
  • Key Industry Players: Siemens Healthineers AG, GE Healthcare Inc., Koninklijke Philips N.V., Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Hitachi, Ltd., Natus Medical Incorporated, Nihon Kohden Corporation, Cadwell Laboratories, Inc., and NeuroLogica Corporation.

Key Takeaways for Decision Makers

  • Emergence of advanced imaging and predictive analytics is driving superior clinical precision and enabling earlier intervention.
  • Growth in digital health and wearable neurodiagnostic solutions supports remote patient monitoring and expanded access to care beyond traditional clinical settings.
  • Integration of artificial intelligence in signal processing allows for improved biomarker identification and streamlined diagnostics, supporting proactive neurology care.
  • Regulatory frameworks for digital health are evolving, with new pathways establishing requirements for software-enabled diagnostic devices and reimbursement alignment.
  • End-user demand is diversifying, with modular, upgradable systems increasing in favor to match flexible budgets and longer procurement cycles.
  • Collaborative partnerships among device manufacturers and technology firms are intensifying, leading to integrated diagnostic solutions and broader market reach.

Tariff Impact on Neurodiagnostic Equipment

US tariff escalation on medical device imports in 2025 is introducing cost pressures for neurodiagnostic equipment suppliers. Increased duties on specialized hardware have prompted manufacturers to reassess sourcing strategies, favor local component sourcing, and strengthen regional manufacturing presence. These trends are prompting hospitals and clinics to evaluate modular system architectures for greater cost efficiency and supply chain resilience. Innovation in digital signal processing and sensor miniaturization is emerging as a strategic response to mitigate reliance on imported precision components.

Methodology & Data Sources

This report leverages extensive primary and secondary research, including peer-reviewed literature, regulatory data, industry reports, and direct interviews with clinicians, executives, and procurement specialists. Analytical approaches incorporate both qualitative insights and quantitative models. Expert panel validation ensures methodological rigor, consistency, and reliability.

Why This Neurodiagnostics Market Report Matters

  • Provides clear market visibility to inform investment and R&D prioritization for manufacturers and healthcare providers.
  • Delivers actionable segment analysis to optimize go-to-market strategies and identify high-impact regional opportunities.
  • Equips leaders with a data-driven foundation for risk management amid evolving tariffs and shifting regulatory landscapes.

Conclusion

The neurodiagnostics sector is experiencing a transformative period defined by technology integration, global expansion, and supply chain adaptation. Informed leadership, adaptable business models, and evidence-based strategic planning are essential to achieve growth and better patient outcomes in today’s competitive landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. AI-driven multimodal imaging analytics improving early detection of neurological disorders
5.2. Portable point-of-care neurodiagnostic devices enabling rapid bedside assessment of brain function
5.3. Wearable EEG monitoring integrated with mobile platforms for continuous neural health tracking
5.4. Growth of multiplex cerebrospinal fluid biomarker assays enhancing early detection of neurodegenerative diseases
5.5. Adoption of cloud-based neuroinformatics platforms for integrated analysis of multimodal diagnostic data
5.6. Expansion of tele-neurology services with remote EEG and imaging capabilities for rural patient care
5.7. Development of high-resolution PET/MRI hybrid scanners to improve early Alzheimer’s disease diagnosis
5.8. Personalized neurodiagnostics integrating genomics and imaging biomarkers for targeted treatment planning
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neurodiagnostics Market, by Technology
8.1. Introduction
8.2. Invasive
8.2.1. Depth Electrode Monitoring
8.2.2. Electrocorticography
8.3. Noninvasive
8.3.1. Electrophysiology
8.3.2. Imaging Modalities
9. Neurodiagnostics Market, by Application
9.1. Introduction
9.2. Alzheimer's Disease
9.2.1. Lewy Body Dementia
9.2.2. Vascular Dementia
9.3. Brain Tumor
9.4. Epilepsy
9.4.1. Focal Epilepsy
9.4.2. Generalized Epilepsy
9.5. Multiple Sclerosis
9.6. Stroke
9.6.1. Hemorrhagic Stroke
9.6.2. Ischemic Stroke
9.7. Trauma
10. Neurodiagnostics Market, by End User
10.1. Introduction
10.2. Ambulatory Clinics
10.2.1. Neurology Clinics
10.2.2. Outpatient Rehabilitation Centers
10.3. Diagnostic Centers
10.3.1. Hospital Owned Diagnostic Centers
10.3.2. Independent Diagnostic Centers
10.4. Home Care
10.5. Hospitals
10.5.1. General Hospitals
10.5.2. Specialty Clinics
10.6. Research Institutes
11. Americas Neurodiagnostics Market
11.1. Introduction
11.2. Brazil
11.3. Canada
11.4. Mexico
11.5. Argentina
11.6. United States
12. Europe, Middle East & Africa Neurodiagnostics Market
12.1. Introduction
12.2. Saudi Arabia
12.3. Switzerland
12.4. Finland
12.5. Turkey
12.6. Germany
12.7. Russia
12.8. Qatar
12.9. South Africa
12.10. Israel
12.11. Denmark
12.12. Nigeria
12.13. Netherlands
12.14. Spain
12.15. Sweden
12.16. Poland
12.17. Norway
12.18. Egypt
12.19. United Arab Emirates
12.20. United Kingdom
12.21. France
12.22. Italy
13. Asia-Pacific Neurodiagnostics Market
13.1. Introduction
13.2. India
13.3. Australia
13.4. Philippines
13.5. Singapore
13.6. China
13.7. Thailand
13.8. Vietnam
13.9. Japan
13.10. Malaysia
13.11. Taiwan
13.12. South Korea
13.13. Indonesia
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Siemens Healthineers AG
14.3.2. GE Healthcare Inc.
14.3.3. Koninklijke Philips N.V.
14.3.4. Canon Medical Systems Corporation
14.3.5. Fujifilm Holdings Corporation
14.3.6. Hitachi, Ltd.
14.3.7. Natus Medical Incorporated
14.3.8. Nihon Kohden Corporation
14.3.9. Cadwell Laboratories, Inc.
14.3.10. NeuroLogica Corporation
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. NEURODIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. NEURODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. NEURODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. NEURODIAGNOSTICS MARKET: RESEARCHAI
FIGURE 22. NEURODIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 23. NEURODIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 24. NEURODIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NEURODIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DEPTH ELECTRODE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DEPTH ELECTRODE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ELECTROPHYSIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ELECTROPHYSIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY IMAGING MODALITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY IMAGING MODALITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY LEWY BODY DEMENTIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY LEWY BODY DEMENTIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY VASCULAR DEMENTIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY VASCULAR DEMENTIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY BRAIN TUMOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY BRAIN TUMOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY FOCAL EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY FOCAL EPILEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GENERALIZED EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GENERALIZED EPILEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HEMORRHAGIC STROKE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HEMORRHAGIC STROKE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TRAUMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TRAUMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY OUTPATIENT REHABILITATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY OUTPATIENT REHABILITATION CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITAL OWNED DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITAL OWNED DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 135. CANADA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. CANADA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. CANADA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
TABLE 138. CANADA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2025-2030 (USD MILLION)
TABLE 139. CANADA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2024 (USD MILLION)
TABLE 140. CANADA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2025-2030 (USD MILLION)
TABLE 141. CANADA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2024 (USD MILLION)
TABLE 144. CANADA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2025-2030 (USD MILLION)
TABLE 145. CANADA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 146. CANADA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 147. CANADA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
TABLE 148. CANADA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
TABLE 149. CANADA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. CANADA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. CANADA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2024 (USD MILLION)
TABLE 152. CANADA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2025-2030 (USD MILLION)
TABLE 153. CANADA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 154. CANADA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 155. CANADA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 156. CANADA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 158. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 159. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
TABLE 160. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 168. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 169. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
TABLE 170. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
TABLE 171. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 250. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
TABLE 252. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2025-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2024 (USD MILLION)
TABLE 254. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2025-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2024 (USD MILLION)
TABLE 258. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 271. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
TABLE 274. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2025-2030 (USD MILLION)
TABLE 275. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2024 (USD MILLION)
TABLE 276. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2025-2030 (USD MILLION)
TABLE 277. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2024 (USD MILLION)
TABLE 280. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2025-2030 (USD MILLION)
TABLE 281. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 282. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 283. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
TABLE 284. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
TABLE 285. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2024 (USD MILLION)
TABLE 288. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2025-2030 (USD MILLION)
TABLE 289. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 290. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 291. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 292. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 293. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 294. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 295. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
TABLE 296. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2025-2030 (USD MILLION)
TABLE 297. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2024 (USD MILLION)
TABLE 298. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2025-2030 (USD MILLION)
TABLE 299. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2024 (USD MILLION)
TABLE 302. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2025-2030 (USD MILLION)
TABLE 303. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 304. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 305. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
TABLE 306. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
TABLE 307. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2024 (USD MILLION)
TABLE 310. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2025-2030 (USD MILLION)
TABLE 311. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 312. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 313. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 314. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 315. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 316. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 317. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
TABLE 318. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2025-2030 (USD MILLION)
TABLE 319. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2024 (USD MILLION)
TABLE 320. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2025-2030 (USD MILLION)
TABLE 321. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2024 (USD MILLION)
TABLE 324. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2025-2030 (USD MILLION)
TABLE 325. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 326. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 327. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
TABLE 328. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
TABLE 329. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2024 (USD MILLION)
TABLE 332. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2025-2030 (USD MILLION)
TABLE 333. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 334. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 335. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 336. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 337. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 338. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 339. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
TABLE 340. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2025-2030 (USD MILLION)
TABLE 341. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2024 (USD MILLION)
TABLE 342. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2025-2030 (USD MILLION)
TABLE 343. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 344. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 345. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2024 (USD MILLION)
TABLE 346. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2025-2030 (USD MILLION)
TABLE 347. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 348. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 349. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
TABLE 350. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
TABLE 351. GERMANY NEURODIAGNOS

Samples

Sample File DOWNLOAD NOW

Companies Mentioned

  • Siemens Healthineers AG
  • GE Healthcare Inc.
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • Hitachi, Ltd.
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Cadwell Laboratories, Inc.
  • NeuroLogica Corporation

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.7 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.19 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Neurodiagnostics - Global Strategic Business Report - Product Image

Neurodiagnostics - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
EUR$5,850USDGBP
Neurodiagnostics Market Report 2025 - Product Image

Neurodiagnostics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Neurodiagnostic and Monitoring Devices Market Report and Forecast 2024-2032 - Product Image

Neurodiagnostic and Monitoring Devices Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
EUR$4,949USDGBP
Neurodiagnostic and Monitoring Devices Patent Landscape Report - Product Image

Neurodiagnostic and Monitoring Devices Patent Landscape Report

  • Report
  • 200 Pages
  • Global
From
EUR$3,869USDGBP
IVD in Cardiology and Neurology - Global Strategic Business Report - Product Image

IVD in Cardiology and Neurology - Global Strategic Business Report

  • Report
  • 378 Pages
  • Global
From
EUR$5,850USDGBP

About the Neurodiagnostics Market

The Neurodiagnostics market is a subset of the Diagnostics industry, focusing on the diagnosis and treatment of neurological disorders. It includes a range of technologies and services, such as imaging, EEG, EMG, and evoked potentials, to diagnose and monitor neurological conditions. Neurodiagnostics also includes the use of biomarkers to detect and monitor neurological diseases. The Neurodiagnostics market is driven by the increasing prevalence of neurological disorders, the development of new technologies, and the growing demand for personalized medicine. Additionally, the increasing focus on preventive healthcare and the rising awareness of neurological disorders are expected to drive the market. Some companies in the Neurodiagnostics market include Philips Healthcare, Siemens Healthineers, GE Healthcare, Medtronic, and Natus Medical. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more